|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
304:870-875
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of nerve growth factor complexed with the shared neurotrophin receptor p75.
|
|
X.L.He,
K.C.Garcia.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Neurotrophins are secreted growth factors critical for the development and
maintenance of the vertebrate nervous system. Neurotrophins activate two types
of cell surface receptors, the Trk receptor tyrosine kinases and the shared p75
neurotrophin receptor. We have determined the 2.4 A crystal structure of the
prototypic neurotrophin, nerve growth factor (NGF), complexed with the
extracellular domain of p75. Surprisingly, the complex is composed of an NGF
homodimer asymmetrically bound to a single p75. p75 binds along the homodimeric
interface of NGF, which disables NGF's symmetry-related second p75 binding site
through an allosteric conformational change. Thus, neurotrophin signaling
through p75 may occur by disassembly of p75 dimers and assembly of asymmetric
2:1 neurotrophin/p75 complexes, which could potentially engage a Trk receptor to
form a trimolecular signaling complex.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structure of NGF complexed with p75. (A) p75 binds
along one side of the NGF homodimer. Backbone representation of
NGF monomer A is colored green; monomer B, blue; and p75,
purple. Disulfide bonds are shown as green sticks. Other figures
have the same coloring scheme. (B) p75 binds across the NGF
dimerization interface. Front view, with a horizontal rotation
of 90° from the orientation of the complex seen in (A) with
NGF depicted as surface and p75 as tube. (C) p75 uses the
opposite side as TNFR-SF members for ligand binding, but both
bind within their ligands' oligomer interfaces. One copy of
TNF-R1 from the TNF-ß-TNF-R1 complex (16) is superimposed
with p75 from the NGF-p75 complex. The two receptors used in
superimposition are depicted in main-chain traces, and the other
molecules in space-filling format.
|
 |
Figure 2.
Fig. 2. The interaction between NGF and p75. (A) Close-up of
the site I interface (NGF monomer A is green; monomer B, blue;
and p75, purple). The backbone is depicted as tubes, and side
chains are depicted as sticks. The buried salt bridge between
NGF Lys88A and p75 Asp41 in site I is highlighted by thickened
side chains. (B) Close-up of the site II interface. (C) Charge
complementarity between the acidic p75 and the basic NGF dimer
is shown as their respective GRASP surfaces. Acidic is red and
basic is blue. (D) A representative electron density map ( A
2F[obs] - F[calc]) around the patch 1 of site I, showing the
knob-in-hole surface complementarity. (E) NT sequence alignment
showing that the p75 contact residues are conserved across all
NTs. Monomer A residues are shaded in green and monomer B
residues shaded in blue. Site I residues are labeled "1," and
site II residues are labeled "2".
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(2004,
304,
870-875)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Niewiadomska,
A.Mietelska-Porowska,
and
M.Mazurkiewicz
(2011).
The cholinergic system, nerve growth factor and the cytoskeleton.
|
| |
Behav Brain Res,
221,
515-526.
|
 |
|
|
|
|
 |
S.Y.Ponomarev,
and
J.Audie
(2011).
Computational prediction and analysis of the DR6-NAPP interaction.
|
| |
Proteins,
79,
1376-1395.
|
 |
|
|
|
|
 |
A.L.Scott,
and
M.S.Ramer
(2010).
Schwann cell p75NTR prevents spontaneous sensory reinnervation of the adult spinal cord.
|
| |
Brain,
133,
421-432.
|
 |
|
|
|
|
 |
K.G.Bath,
and
F.S.Lee
(2010).
Neurotrophic factor control of adult SVZ neurogenesis.
|
| |
Dev Neurobiol,
70,
339-349.
|
 |
|
|
|
|
 |
K.K.Teng,
S.Felice,
T.Kim,
and
B.L.Hempstead
(2010).
Understanding proneurotrophin actions: Recent advances and challenges.
|
| |
Dev Neurobiol,
70,
350-359.
|
 |
|
|
|
|
 |
M.Cazorla,
A.Jouvenceau,
C.Rose,
J.P.Guilloux,
C.Pilon,
A.Dranovsky,
and
J.Prémont
(2010).
Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice.
|
| |
PLoS One,
5,
e9777.
|
 |
|
|
|
|
 |
A.Caporali,
and
C.Emanueli
(2009).
Cardiovascular actions of neurotrophins.
|
| |
Physiol Rev,
89,
279-308.
|
 |
|
|
|
|
 |
B.L.Hempstead
(2009).
Commentary: Regulating proNGF Action: Multiple Targets for Therapeutic Intervention.
|
| |
Neurotox Res,
16,
255-260.
|
 |
|
|
|
|
 |
E.C.Johnson,
Y.Guo,
W.O.Cepurna,
and
J.C.Morrison
(2009).
Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.
|
| |
Exp Eye Res,
88,
808-815.
|
 |
|
|
|
|
 |
E.M.Quistgaard,
P.Madsen,
M.K.Grøftehauge,
P.Nissen,
C.M.Petersen,
and
S.S.Thirup
(2009).
Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain.
|
| |
Nat Struct Mol Biol,
16,
96-98.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Yano,
R.Torkin,
L.A.Martin,
M.V.Chao,
and
K.K.Teng
(2009).
Proneurotrophin-3 is a neuronal apoptotic ligand: evidence for retrograde-directed cell killing.
|
| |
J Neurosci,
29,
14790-14802.
|
 |
|
|
|
|
 |
L.K.Ely,
S.Fischer,
and
K.C.Garcia
(2009).
Structural basis of receptor sharing by interleukin 17 cytokines.
|
| |
Nat Immunol,
10,
1245-1251.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Vilar,
I.Charalampopoulos,
R.S.Kenchappa,
A.Simi,
E.Karaca,
A.Reversi,
S.Choi,
M.Bothwell,
I.Mingarro,
W.J.Friedman,
G.Schiavo,
P.I.Bastiaens,
P.J.Verveer,
B.D.Carter,
and
C.F.Ibáñez
(2009).
Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers.
|
| |
Neuron,
62,
72-83.
|
 |
|
|
|
|
 |
P.A.Barker
(2009).
A p75(NTR) pivoting paradigm propels perspicacity.
|
| |
Neuron,
62,
3-5.
|
 |
|
|
|
|
 |
A.Hoffmann,
P.Neumann,
A.Schierhorn,
and
M.T.Stubbs
(2008).
Crystallization of Spätzle, a cystine-knot protein involved in embryonic development and innate immunity in Drosophila melanogaster.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
64,
707-710.
|
 |
|
|
|
|
 |
J.J.Watson,
S.J.Allen,
and
D.Dawbarn
(2008).
Targeting nerve growth factor in pain: what is the therapeutic potential?
|
| |
BioDrugs,
22,
349-359.
|
 |
|
|
|
|
 |
J.M.Fletcher,
C.J.Morton,
R.A.Zwar,
S.S.Murray,
P.D.O'Leary,
and
R.A.Hughes
(2008).
Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor.
|
| |
J Biol Chem,
283,
33375-33383.
|
 |
|
|
|
|
 |
L.Puglielli
(2008).
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?
|
| |
Neurobiol Aging,
29,
795-811.
|
 |
|
|
|
|
 |
V.Freund-Michel,
and
N.Frossard
(2008).
The nerve growth factor and its receptors in airway inflammatory diseases.
|
| |
Pharmacol Ther,
117,
52-76.
|
 |
|
|
|
|
 |
Y.Gong,
P.Cao,
H.J.Yu,
and
T.Jiang
(2008).
Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex.
|
| |
Nature,
454,
789-793.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Tuffereau,
K.Schmidt,
C.Langevin,
F.Lafay,
G.Dechant,
and
M.Koltzenburg
(2007).
The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection.
|
| |
J Virol,
81,
13622-13630.
|
 |
|
|
|
|
 |
M.Kliemannel,
R.Golbik,
R.Rudolph,
E.Schwarz,
and
H.Lilie
(2007).
The pro-peptide of proNGF: structure formation and intramolecular association with NGF.
|
| |
Protein Sci,
16,
411-419.
|
 |
|
|
|
|
 |
N.J.Gay,
and
M.Gangloff
(2007).
Structure and function of Toll receptors and their ligands.
|
| |
Annu Rev Biochem,
76,
141-165.
|
 |
|
|
|
|
 |
P.A.Barker
(2007).
High affinity not in the vicinity?
|
| |
Neuron,
53,
1-4.
|
 |
|
|
|
|
 |
T.Wehrman,
X.He,
B.Raab,
A.Dukipatti,
H.Blau,
and
K.C.Garcia
(2007).
Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.
|
| |
Neuron,
53,
25-38.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Kinkade,
and
C.F.Ware
(2006).
The DARC conspiracy--virus invasion tactics.
|
| |
Trends Immunol,
27,
362-367.
|
 |
|
|
|
|
 |
E.J.Coulson
(2006).
Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer's disease?
|
| |
J Neurochem,
98,
654-660.
|
 |
|
|
|
|
 |
L.F.Reichardt
(2006).
Neurotrophin-regulated signalling pathways.
|
| |
Philos Trans R Soc Lond B Biol Sci,
361,
1545-1564.
|
 |
|
|
|
|
 |
M.Pehar,
M.R.Vargas,
K.M.Robinson,
P.Cassina,
P.England,
J.S.Beckman,
P.M.Alzari,
and
L.Barbeito
(2006).
Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons.
|
| |
Free Radic Biol Med,
41,
1632-1644.
|
 |
|
|
|
|
 |
N.J.Gay,
M.Gangloff,
and
A.N.Weber
(2006).
Toll-like receptors as molecular switches.
|
| |
Nat Rev Immunol,
6,
693-698.
|
 |
|
|
|
|
 |
S.Capsoni,
and
A.Cattaneo
(2006).
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.
|
| |
Cell Mol Neurobiol,
26,
619-633.
|
 |
|
|
|
|
 |
Z.G.Gao,
and
K.A.Jacobson
(2006).
Keynote review: allosterism in membrane receptors.
|
| |
Drug Discov Today,
11,
191-202.
|
 |
|
|
|
|
 |
A.Nykjaer,
T.E.Willnow,
and
C.M.Petersen
(2005).
p75NTR--live or let die.
|
| |
Curr Opin Neurobiol,
15,
49-57.
|
 |
|
|
|
|
 |
J.P.Aurikko,
B.T.Ruotolo,
J.G.Grossmann,
M.C.Moncrieffe,
E.Stephens,
V.M.Leppänen,
C.V.Robinson,
M.Saarma,
R.A.Bradshaw,
and
T.L.Blundell
(2005).
Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin receptor, p75NTR.
|
| |
J Biol Chem,
280,
33453-33460.
|
 |
|
|
|
|
 |
K.Susen,
and
A.Blöchl
(2005).
Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75.
|
| |
J Mol Med,
83,
720-735.
|
 |
|
|
|
|
 |
N.F.Schor
(2005).
The p75 neurotrophin receptor in human development and disease.
|
| |
Prog Neurobiol,
77,
201-214.
|
 |
|
|
|
|
 |
U.L.Rahbek,
S.Dissing,
C.Thomassen,
A.J.Hansen,
and
K.Tritsaris
(2005).
Nerve growth factor activates aorta endothelial cells causing PI3K/Akt- and ERK-dependent migration.
|
| |
Pflugers Arch,
450,
355-361.
|
 |
|
|
|
|
 |
Y.C.Tong,
and
J.T.Cheng
(2005).
Changes in bladder nerve-growth factor and p75 genetic expression in streptozotocin-induced diabetic rats.
|
| |
BJU Int,
96,
1392-1396.
|
 |
|
|
|
|
 |
F.C.Bronfman,
and
M.Fainzilber
(2004).
Multi-tasking by the p75 neurotrophin receptor: sortilin things out?
|
| |
EMBO Rep,
5,
867-871.
|
 |
|
|
|
|
 |
P.A.Barker
(2004).
p75NTR is positively promiscuous: novel partners and new insights.
|
| |
Neuron,
42,
529-533.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |